Headlines
- Assetmark Inc. boosts its stake in CVS Health
- Institutional investors continue to increase CVS Health holdings
- CVS Health shows significant interest from large investors
Assetmark Inc. increased its position in CVS Health Co. (NYSE:CVS) by nearly 10% during the third quarter, according to its recent filing with the Securities and Exchange Commission. The institutional investor now holds over 400,000 shares of CVS Health, further strengthening its investment in the leading pharmacy operator.
Other institutional investors have also shown increasing interest in CVS Health. GSA Capital Partners LLP acquired a new position in CVS during the first quarter. Additionally, Empirical Financial Services LLC raised its stake by over 7%, adding to its holdings of CVS Health shares. Atomi Financial Group Inc. also made a notable move, increasing its stake by nearly 25% during the same period. Sei Investments Co. and Meeder Advisory Services Inc. also expanded their positions in CVS Health, reflecting the confidence placed in the company by institutional investors.
These developments highlight strong institutional support for CVS Health, which is now owned by a substantial percentage of institutional investors and hedge funds. With over 80% of CVS Health's stock held by these entities, the company continues to attract significant attention from large-scale investors, signaling their confidence in the company’s prospects.
The growing involvement of institutional investors in CVS Health underscores its position as a key player in the healthcare and pharmacy sector. This wave of institutional investment could suggest a strong future for the company, with continued investor interest likely to shape its upcoming performance.
The ticker for CVS Health is NYSE: CVS, and its shares are drawing the attention of several prominent investors, signaling confidence in its long-term growth.